Index | Recent Threads | Unanswered Threads | Who's Active | Guidelines | Search |
![]() |
World Community Grid Forums
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
No member browsing this thread |
Thread Status: Active Total posts in this thread: 100
|
![]() |
Author |
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
A new analysis of the West Africa Ebola outbreak finds that just 3% of patients infected 61% overall
Targeting such superspreaders subsets, US and European researchers write in the Proceedings of the National Academy of Sciences, could shorten future epidemic's run and curtail its spread. http://tinyurl.com/jdtqxww ![]() |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Ebola Research Update
There are currently no licensed Ebola vaccines but several pharma companies are developing potential candidates. Merck and Janssen are the two companies furthest along in the development of an Ebola Vaccine. http://www.pharmavoice.com/article/2017-3-Ebola-Research ![]() |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
World Health Organization confirms second Ebola case in DRC and fears 17 more
The World Health Organization (WHO) has confirmed a second case of Ebola in the Democratic Republic of Congo (DRC) and suspects 17 others. http://www.itv.com/news/2017-05-14/world-heal...in-drc-and-fears-17-more/ ![]() |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Antibodies from Ebola survivor could lead to treatments and vaccines
NIH Research Matters reports: -Antibodies from an Ebola survivor protected mice and ferrets against all three ebolaviruses that cause outbreaks in humans. -The findings will help form the development of potential treatments and vaccines for Ebola and related viruses. https://www.nih.gov/news-events/nih-research-...-lead-treatments-vaccines ![]() |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Overcoming Operational Challenges to Ebola Case Investigation in Sierra Leon
Deficiencies in transportation and communications, low frontline staff morale, and mistrust among communities, among other operational challenges, greatly limited Ebola case investigation in Sierre Leon. http://www.ghspjournal.org/content/early/2017...-D-17-00126.abstract.html ![]() |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Ebola vaccine tested in adults and children in Africa hailed a success
Experts at St. George's, University of London, have reported that an Ebola vaccine is safe for children as well as adults and produces an immune response. https://www.sciencedaily.com/releases/2017/10/171006142352.htm ![]() |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia-NEJM
A randomized placebo-controlled phase 2 trial of two vaccines that was rapidly initiated and completed in Liberia showed the capability of conducting rigorous research during an outbreak. By 1 month after vaccination, the vaccines had elicited immune responses that were largely maintained through 12 months http://www.nejm.org/doi/full/10.1056/NEJMoa1614067 ![]() |
||
|
Jim Slade
Veteran Cruncher Joined: Apr 27, 2007 Post Count: 665 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Knowledge, Attitudes, and Practices Related to Ebola Virus Disease at the End of a National Epidemic-Guinea, August 2015/MMWR
The Center for Disease Control and Prevention reports that health communication and social mobilization efforts to improve the public's knowledge, attitudes, and practices (KAP) regarding Ebola virus disease (Ebola) were important in controlling the 2014-2016 Ebola epidemic in Guinea which resulted in 3,814 reported Ebola cases and 2,544 deaths. https://www.cdc.gov/mmwr/volumes/66/wr/mm6641a4.htm?s_cid=mm6641a4_e ![]() |
||
|
Former Member
Cruncher Joined: May 22, 2018 Post Count: 0 Status: Offline |
Researchers Inhibit Ebola Virus
The incurable Ebola virus has long been feared due to its high mortality rate and danger of infection. Now researchers from the University of Copenhagen and Phillips Universität Marburg have succeeded in inhibiting the virus in cell cultures. The researchers hope to be able to continue doing animal testing and developing an actual drug. - full article in English |
||
|
QuantumEthos
Senior Cruncher Joined: Jul 2, 2011 Post Count: 336 Status: Offline Project Badges: ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
|
||
|
|
![]() |